Tesla's Back In Favor, But Goldman Sachs Is Still Selling

Loading...
Loading...

Tesla Inc TSLA has rebounded nearly 20 percent since reporting first-quarter production figures last week. One analyst won’t back the rally.

The Rating

Goldman Sachs analyst David Tamberrino maintained a Sell rating on Tesla and lowered the price target from $205 to $195.

The Thesis

Tamberrino attributes the recovery to Tesla’s reiterated production rate target of 5,000 Model 3s per week and its announced ability to achieve its goals without a 2018 debt or equity raise. By his assessment, neither strategy will hold.

The analyst expects Tesla to achieve a second-quarter sustainable production rate below Q1's 2,000-vehicle end rate. Amid February’s Fremont line improvements, 1,400 is more likely, Tamberrino said. 

“While this is an improvement from our previous forecast (adjusted accordingly), it is below revised consensus forecasts as well as below bullish investors’ expectations, in our view," the analyst said in a Tuesday note. 

Between Model 3 cash burn and growth targets, Tamberrino said he expects Tesla to raise capital at some point this year.

Model S and X demand could be stunted by rising competition and the loss of the electric vehicle tax credit in the back half of the year, he said. 

Price Action

At the time of publication, Tesla shares were trading up 4.53 percent at $302.77.

Related Links:

Bernstein: 'Uncertainties Loom Ahead' For Tesla Following Q1 Delivery Report

A Model 3 Miss, Capital Questions And Factory Shutdowns: What Wall Street Says About Tesla's Q1 Deliveries

Photo by John Cummings/Wikimedia. 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetReiterationTop StoriesAnalyst RatingsDavid TamberrinoGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...